Nuveen’s AbbVie ABBV Stock Holding History

Nuveen’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-43,200	Closed	-$5K	–	3316
2021 Q3	$5K	Buy	+43,200	New	+$4.94M	﹤0.01%	3346
2021 Q2	–	Sell	-49,500	Closed	-$5K	–	3349
2021 Q1	$5K	Buy	+49,500	New	+$5.29M	﹤0.01%	3323
2020 Q2	–	Sell	-51,100	Closed	-$4K	–	3266
2020 Q1	$4K	Buy	+51,100	New	+$4.35M	﹤0.01%	3158

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Nuveen's ABBV Position: Q2 2026 in Review

Nuveen reduced its AbbVie (ABBV) stake by 14% in Q2 2026, selling an estimated $345M and leaving 9,509,991 shares worth $2.39B. The position accounts for 0.57% of the portfolio, ranked #30.

Nuveen first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.62B in Q1 2022. 4,232 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Nuveen held 9,509,991 shares of AbbVie worth $2.39B as of Q2 2026.
Nuveen sold 1,605,168 AbbVie shares in Q2 2026, an estimated $345M.
AbbVie made up 0.57% of Nuveen's portfolio in Q2 2026, its #30 holding.
Nuveen first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
Nuveen's AbbVie position peaked at $2.62B in Q1 2022.
4,232 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.